News

Filter

Current filters:

DiovanFemaraZometa

1 to 9 of 13 results

Novartis posts 50% 4th-qtr 2009 profits rise and promotes drugs chief Jimenez to CEO; other top changes

26-01-2010

Swiss drugmaker Novartis this morning said that it had achieved record results in 2009 as momentum from…

AfinitorAlconAliskiren TabletsAmlodipine and ValsartanAstraZenecaCanakinumab InjectionDeferasiroxDiovanEuropeeverolimusExelonExelon PatchExforgeExjadeFemaraFinancialGleevecIlarisImatinib MesylateLansoprazoleLetrozoleLucentisNovartisOctreotide AcetatePharmaceuticalPrevacidPrevacid NapraPACRanibizumab InjectionReclastRivastigmine TartrateRivastigmine Transdermal SystemSandostatinSandozTekturnavalsartanzoledronic acidZoledronic Acid InjectionZometa

Novartis delivers strong new product momentum; raises full-year 2009 guidance

22-10-2009

Swiss drug major Novartis reported third-quarter 2009 results with 3% growth in group net sales to $11.1…

AfinitorAlconAmlodipine and ValsartanCanakinumab InjectionDeferasiroxDiovaneverolimusExforgeExjadeFemaraFinancialGleevecIlarisImatinib MesylateLetrozoleLucentisNovartisNystatinOctreotide AcetateOralPharmaceuticalRanibizumab InjectionReclastSandostatinSandozvalsartanzoledronic acidZoledronic Acid InjectionZometa

Novartis' 1st-qtr 2009 results boosted by new products

24-04-2009

Swiss drug major Novartis' first-quarter profit was ahead of expectations at $1.96 billion, a 15% drop…

AfinitorAliskiren TabletsAmlodipine and ValsartanAspirinBayerBayerDeferasiroxDiovanDiovan HCTeverolimusExelonExelon PatchExforgeExjadeFemaraGleevecImatinib MesylateLetrozoleLucentisNexavarNovartisOmalizumabPfizerRanibizumab InjectionReclastRivastigmine TartrateRivastigmine Transdermal SystemSorafenibSunitinib MalateSutentTekturnavalsartanValsartan and HydrochlorothiazideXolairzoledronic acidZoledronic Acid InjectionZometa

Novartis profit up 32% in 3rd qtr

27-10-2008

Swiss drug major Novartis' profit grew 32% in the third quarter of 2008, versus the same period of the…

Aliskiren TabletsAmlodipine and ValsartanDiovanExforgeFemaraGleevecImatinib MesylateLetrozoleNovartisSandozTekturnavalsartanzoledronic acidZometa

Novartis' 2nd-qrt just beats forecasts, with sales up 10%, profits 18% higher

23-07-2007

Swiss pharmaceutical major Novartis has posted a solid set of second-quarter and first-half 2007 results,…

Amlodipine BesylateAmlodipine Besylate and Benazepril HClBenazeprilDiovanFemaraGleevecImatinib MesylateLamisilLetrozoleLotensinLotrelNorvascNovartisOctreotide AcetateSandostatinSandozSeldaneTegaserod MaleateTerbinafineTerfenadinevalsartanZelnormzoledronic acidZometa

Novartis' 1st-qtr 2007 profit up 11% to $2.17B on strong sales of cancer drugs and Diovan

30-04-2007

Swiss drug major Novartis says that its first-quarter 2007 profit rose 11% on the like, year ago period,…

Amlodipine BesylateAmlodipine Besylate and Benazepril HClBenazeprilDiovanFemaraGleevecImatinib MesylateLetrozoleLotensinLotrelNorvascNovartisTegaserod MaleatevalsartanZelnormzoledronic acidZometa

Novartis' sales up 17% to $7.2 B in 2006, with eight product launches due in 2007

29-01-2007

Swiss drug major Novartis said that a strong health care portfolio and continued innovation in its pharmaceutical…

Aliskiren TabletsAmlodipine and ValsartanAmlodipine BesylateAmlodipine Besylate and Benazepril HClBenazeprilDeferasiroxDiovanExelonExforgeExjadeFemaraGleevecImatinib MesylateLamisilLetrozoleLotensinLotrelNorvascNovartisOmalizumabRivastigmine TartrateSandozTegaserod MaleateTekturnaTerbinafineTestosteronetransdermalvalsartanVerteporfin InjVisudyneXolairZelnormzoledronic acidZometa

Oncology and cardiovascular drugs push Novartis' 2nd-qtr results

25-07-2005

Leading Swiss pharmaceutical firm Novartis delivered a strong set of second-quarter 2005 results, with…

Amlodipine BesylateAmlodipine Besylate and Benazepril HClBenazeprilCyclosporineDiovanElidelFemaraGleevecImatinib MesylateLamisilLetrozoleLotensinLotrelLucentisNeoralNorvascNovartisNystatinOralPimecrolimus CreamRanibizumab InjectionSandozTegaserod MaleatetelbivudineTerbinafineTyzekavalsartanVerteporfin InjVisudyneZelnormzoledronic acidZometa

1 to 9 of 13 results

COMPANY SPOTLIGHT

Menarini

Back to top